skip to main content

Mesalazine adherence — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyGastrointestinal TherapeuticsMesalazine adherenceGPhC CRA

A patient with ulcerative colitis says they stop mesalazine when symptoms settle because they dislike taking tablets. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Continue maintenance treatment as prescribed and discuss concerns with the IBD team

Mesalazine may be used to maintain remission, and poor adherence increases relapse risk. The best answer addresses the key safety, legal or pharmaceutical care issue in the vignette. The other options would either delay appropriate care, create a new risk, or fail to resolve the issue. This is consistent with the cited UK reference for safe pharmacy practice.

Reference: https://www.pharmacyregulation.org/students-and-trainees/pharmacist-education-and-training/registration-assessment